>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • NSTG +9.2% (guidance), U +5.9% (guidance and Chairman and CEO retiring), HON +1.3% (guidance), PEP +0.8%
Other news:
  • COHR +12.7% (announced that Denso (DNZOY) and Mitsubishi Electric (MIELY) have agreed to invest $1 billion in its silicon carbide business; COHR narrows Q1 revs guidance)
  • LXRX +9% (INPEFA receives preferred formulary status)
  • H +5.4% (replacing NATI in the S&P MidCap 400)
  • PSTX +4.4% (appoints new Chairman and CEO)
  • OCS +2.4% (phase 3 stage 1 DIAMOND trial results of OCS-01)
  • STLA +2.3% (announces additional 570 employees on layoff)
  • NNDM +2.2% (stated that business functions as usual)
  • OLMA +1.9% (announces an amendment to existing clinical collaboration and supply agreement with Novartis)
  • BKD +1.6% (reports September 2023 occupancy)
  • AOS +1.5% (increases dividend)
  • AL +1.2% (announced an update on aircraft investments and sales activities occurring in the third quarter of 2023)
  • KMDA +1.2% (continues to conduct its business operations in Israel with no effect on business continuity and its global supply of products is not expected to be interrupted)
  • HUT +1% (reports Sept metrics)
Analyst comments:
  • ACAD +4% (upgraded to Overweight from Neutral at JP Morgan)
  • RIVN +3.2% (upgraded to Buy from Neutral at UBS)
  • EA +1.8% (upgraded to Buy from Neutral at BofA Securities)
  • SBRA +1.8% (upgraded to Buy from Neutral at BofA Securities)

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • NEOG -3.3%
Other news:
  • AKRO -62.7% (reports 36-week analysis of 96-week phase 2b symmetry study with a trend on fibrosis improvement and statistically significant results for nash resolution markers of liver injury and fibrosis insulin sensitization and lipoproteins)
  • VTYX -17.5% (positive results from VTX002 Phase 2 trial)
  • PD -6.4% ($350 mln convertible senior notes)
  • BBIO -4.9% (NEJM publication of positive encaleret proof-of-concept phase 2b results in patients with autosomal dominant hypocalcemia type 1)
  • CYRX -3.2% (new partnership with Be The Match BioTherapies)
  • EFXT -3.1% (appoints Preet Dhindsa as interim Chief Financial Officer)
  • UROY -2.9% (entered into an agreement with a syndicate of underwriters led by BMO Capital Markets as sole bookrunner under which the underwriters have agreed to purchase on a bought deal basis 10205000 common shares at a price of $2.94/share)
  • XENE -0.7% (publishes XEN1101 Phase 2b results)
Analyst comments:
  • JNPR -3.5% (downgraded to Neutral from Overweight at JP Morgan)
  • GLW -2.7% (downgraded to Neutral from Overweight at JP Morgan)
  • NTST -2.3% (downgraded to Underperform from Neutral at BofA Securities)
  • STWD -1.5% (downgraded to Mkt Perform from Outperform at Keefe Bruyette)
  • SRC -1.4% (downgraded to Underperform from Neutral at BofA Securities)
  • NEP -1% (downgraded to Neutral from Buy at UBS)

Challenges : Pourquoi la stratégie d'Alstom déraille

Pourquoi la stratégie d'Alstom déraille

C’était une belle occasion de vanter les avancées du TGV M. Las! le 6 octobre, Henri Poupart-Lafarge a dû se faire porter pâle pour les premiers essais du train du futur, au technicentre de la SNCF à Paris. La veille, le patron d’Alstom avait vu le titre de son groupe, numéro deux mondial du rail derrière le chinois CRRC, dévisser de près de 38% en quelques heures, suite à l’annonce de difficultés de trésorerie sur l’exercice en cours. Il faut dire qu'en annonçant avoir enregistré un flux de trésorerie disponible négatif de 1,15 milliard d'euros au premier semestre et une fourchette allant de -500 et -750 millions d'euros sur l'exercice en cours, le groupe a ravivé les spéculations sur sa santé financière et le risque d'une augmentation de capital. L’alerte était d’autant plus surprenante pour le marché que l’entreprise anticipait des entrées "significativement positives" sur l’année.
10% de croissance par an en moyenne
Certes, avec 3,5 milliards de liquidité, l’entreprise n’est pas aux abois, mais elle souffre d’un décalage de plus en plus flagrant entre les commandes et ses capacités à les honorer. "Il est temps de faire de la croissance rentable, plus ciblée, estime un bon connaisseur d’Alstom, questionnant la hausse d'activité de 10% par an en moyenne de la division "Matériel Roulant" du groupe. Les objectifs sont trop ambitieux. Aujourd’hui la complexité du business fait que la croissance génère des besoins en fonds de roulement excessifs par rapport aux avances de leurs clients. Ils ont par ailleurs surestimé leur capacité d’intégration de Bombardier Transport", racheté début 2021.

87 milliards d'euros de commandes
La demande est en effet très soutenue dans le secteur ferroviaire. Pour honorer un carnet de commandes dépassant désormais 87 milliards d’euros –dont près de 60% engrangés en deux ans et demi–, Alstom doit accélérer la montée en cadence de ses usines, surtout pour la livraison de trains, de RER et de rames de métro. Et pour éviter toute rupture d’approvisionnement, il constitue des stocks coûteux.

Dans le même temps les retards s’accumulent. La livraison de 443 trains périurbains électriques Aventra à différents opérateurs au Royaume-Uni, un contrat hérité du portefeuille de Bombardier, n’est pas attendue avant 2024-2025. Privant de facto le constructeur de certaines avances de trésorerie. Pour autant, Alstom connaît aussi des retards sur d'autres programmes venus de son propre portefeuille. Les choses se corsent ainsi aux Etats-Unis où le Français a signé en 2016 un contrat de 1,8 milliard d’euros pour fournir des rames à grande vitesse entre Boston et Washington qui devaient entrer en service en 2022. Or les Américains ne cessent de réclamer des améliorations techniques pour homologuer les trains.

Près d'un an de retard pour le TGV du futur
En France également, le TGV M n'est pas loin d'accuser un an de retard. Les premiers exemplaires de cette nouvelle génération sont attendus par la SNCF vers mi-2025. C'est aussi le cas pour les nouvelles rames de RER B, qui ont encore pris 13 mois de retard et n'arriveront pas avant 2027.

Malgré les mauvaise nouvelles, la direction du groupe reste sereine. "Nous avons confirmé nos prévisions de profitabilité, entre 8 et 10% en 2025-2026, avance-t-on en interne. Quant aux contrats non rentables hérités de Bombardier, ils sont en majorité derrière nous." Reste un niveau de dette annuelle nette –3 milliards– trop élevée. Si l’augmentation de capital crainte par les marchés n’est pas à l’ordre du jour, elle n’est pas pour autant complètement écartée par le constructeur, ni la réalisation d’éventuelles cessions d’actifs.

FT : China’s largest private developer Country Garden warns of default

China’s largest private developer Country Garden warns of default
Company has about $200bn in liabilities and close to $10bn in dollar-denominated debt

Country Garden, China’s largest private developer, has warned of a potential default on its international debts in a significant blow to the country’s embattled property sector.

The company, which has about $200bn in liabilities and close to $10bn in dollar-denominated debt, said in a statement to the Hong Kong stock exchange that it had missed a due payment of HK$470mn ($60mn) on some of its debts and also expected it “will not be able to meet all of its offshore payment obligations” when they are due.

“Such non-payment may lead to relevant creditors of the group demanding acceleration of payment of the relevant indebtedness owed to them or pursuing enforcement action,” the company said on Tuesday.

The statement underscores a sudden deterioration in the financial health of Country Garden, which had so far this year withstood a sector-wide property cash crunch following the 2021 default of its peer Evergrande.

The potential default also adds to concerns over China’s property sector, which typically drives more than a quarter of the country’s economic activity but has for two years been plagued by construction delays after a wave of developer bond defaults, as well as by falling demand.

Country Garden said its sales for the first nine months were down 44 per cent on the same period in 2022 and fell in September for the sixth consecutive month.

“As there has not been any material, industry-wide improvement in property sales, the group faces significant uncertainty regarding asset disposals, and its liquidity position is expected to remain very tight in the short to medium term,” the group said.

Country Garden missed international bond payments in August, triggering a 30-day grace period, within which it narrowly avoided default last month. It said on Tuesday that it expected not to make payments “within relevant grace periods”, one of which expires next week.

The fate of Country Garden, which was previously seen as healthier than other private developers and eligible for government support programmes, will put pressure on Chinese policymakers who initially sought to curtail developer leverage in 2020.

Beijing has in recent months increased its support for the property sector and cut rates, while individual cities have also relaxed policies designed to constrain overheating prices. However, the industry’s outlook is clouded by uncertainty over unresolved defaults.

The restructuring plan of Evergrande, the world’s most indebted developer that first missed payments on its international debts two years ago, was derailed late in September after the company cited an unspecified “investigation” and pointed to regulatory constraints on issuing new notes.

Advisers to international bondholders holding about $6bn in the company hit out at the developer on Monday, saying that they had been “left in the dark” following the abrupt cancellation of the plan.

The bondholder group said the current “base case” was that the company would be liquidated at a winding-up hearing in Hong Kong at the end of the month.

Sunac, another former major private developer in China, received approval this month for its own $10bn restructuring plan from a Hong Kong court. Country Garden’s woes have also compounded fears that the crisis will spill over into other sectors.

Over the summer, Zhongrong, a giant in China’s $3tn shadow finance industry that lent money to developers, missed payments to customers.

In a separate statement to the Financial Times, Country Garden said it hoped to “comprehensively solve the company’s current overseas debt risks”. In September, it disclosed $7bn of losses in the first half of the year.

>>> Europe : Brokers Upgrades & Downgrades - 10th of October 2023 V3(++)

>>> Up
* Anglo American Raised to Neutral at Oddo BHF (++)
* Bayer Raised to Hold at HSBC; PT 43 euros
* BioPharma Credit Raised to Buy at Stifel (+)
* Chr. Hansen Raised to Buy at DNB Markets; PT 536 kroner
* Eiffage Raised to Buy at Jefferies; PT 115 euros
* Greencore Group Raised to Buy at HSBC; PT 90 pence (++)
* Hexagon Raised to Buy at Carnegie; PT 120 kronor (++)
* Novozymes Raised to Buy at DNB Markets; PT 350 kroner
* Pagegroup's MSCI ESG Rating Raised to A from BBB
* Pandora PT Raised to 1,000 kroner from 900 kroner at BofA (++)
* Sacyr Raised to Buy at Alantra Equities; PT 3.60 euros (+)
* SSAB Raised to Overweight at Barclays; PT 85 kronor
* Swedbank Raised to Buy at Deutsche Bank; PT 260 kronor
* Tele2 Raised to Buy at Redburn; PT 96 kronor (+)
* Viaplay Raised to Hold at DNB Markets; PT 30 kronor
* Wolters Kluwer PT Raised to 142 euros at Morgan Stanley

>>> Down
* Croda Cut to Hold at HSBC; PT 5,000 pence
* Deutsche PBB Cut to Reduce at Kepler Cheuvreux; PT 6 euros (++)
* EuroAPI Cut to Neutral at Oddo BHF; PT 11.80 euros (+)
* Euronav Cut to Hold at Stifel; PT 17.49 euros
* Euronav Cut to Neutral at Citi; PT 17.56 euros
* Fluidra Cut to Underperform at BNPP Exane; PT 15 euros
* Lucas Bols Cut to Hold at Kepler Cheuvreux; PT 18 euros (++)
* Outokumpu Cut to Equal-Weight at Barclays; PT 4.30 euros
* Qorvo Cut to Sell at Citi (++)
* Starwood Property Cut to Market Perform at KBW; PT $20
* Telenor Cut to Sell at DNB Markets; PT 110 kroner
* Tesla PT Cut to $250 from $265 at Jefferies
* Treatt Cut to Hold at Numis; PT 500 pence (++)
* Vitesco Cut to Hold at HSBC; PT 93 euros
* Vitesco Cut to Hold at M.M. Warburg; PT 91 euros (+)
* Watches of Switzerland PT Cut to 550 pence at Peel Hunt (++)
* YIT Cut to Sell at Inderes; PT 1.60 euros

>>> Initiation
* Airtel Africa Rated New Neutral at FBNQuest; PT 123.03 pence (++)
* ARM Holdings PLC ADRs Rated New Buy at Daiwa; PT $63
* ARM Holdings PLC ADRs Rated New Outperform at Oddo BHF; PT $70
* ARM Holdings PLC ADRs Rated New Buy at BofA; PT $65(Earlier)
* AutoZone Rated New Outperform at Cowen; PT $2,975
* Coty Rated New Hold at Kepler Cheuvreux; PT $11.66 (++)
* Frontier Developments Reinstated Under Review at Liberum
* H&M Rated New Accumulate at Inderes; PT 165 kronor (+)
* Maersk Reinstated Equal-Weight at Morgan Stanley
* Sandoz Group Rated New Buy at Redburn; PT 47 Swiss francs (+)
* Schlumberger Rated New Buy at SocGen on Decades of Growth
* Sensirion Rated New Market Perform at ZKB (+)
* Severn Trent Reinstated Outperform at BNPP Exane; PT 2,725 pence
* SKF Reinstated Underweight at Barclays; PT 162 kronor
* Somec Rated New Hold at Kepler Cheuvreux; PT 28.50 euros (++)
* Trelleborg Rated New Overweight at Barclays; PT 324 kronor
* Vinfast Auto Ltd Rated New Buy at Chardan Capital Markets

>>> Call
*Citi’s Montagu Says US Futures Positioning Is Moderately Bearish (+)
* Eiffage Raised to Buy at Jefferies, Cautious on Fraport, Skanska
* EuroAPI Estimates Slashed at Morgan Stanley Following Warning
* Fluidra Cut as BNPP Exane Questions if Earnings Yet at Trough (+)
* Maersk Equal-Weight, Net Cash Protects Downside: Morgan Stanley

FT : Bank of England pushes to double liquidity requirements for money market fu

Bank of England pushes to double liquidity requirements for money market funds
Officials have recommended the £250bn sterling money market fund sector holds more easily sellable assets

Bank of England officials are pushing to double the amount of easily sellable assets that money market funds have to hold, the latest move by financial watchdogs globally to reduce shadow banking risks.

The BoE’s financial stability experts recommended the tighter liquidity requirements for the £250bn of sterling money market funds as they cited risks including geopolitical tensions and “stretched” valuations in some markets.

“The overall risk environment remains challenging,” the BoE’s quarterly financial stability statement said on Tuesday. It also cited rising household indebtedness and the tripling prevalence of 35-year plus mortgages in the UK since 2021.

Shadow banks, which span a broad sweep of the financial sector including hedge funds to insurers to non-bank lenders, have been at the centre of a spate of recent crises, including the dash for cash in March 2020 when markets seized up as the pandemic hit and the UK gilts crisis in late 2022.

The statement on Tuesday was the latest in a series of measures aimed at reducing risk in various areas of the shadow banking sector.

The UK has already imposed higher liquidity standards on liability-driven investment vehicles used by pension funds. The leveraged vehicles exacerbated the 2022 gilts crisis through a mass sell-off of bonds in the aftermath of Liz Truss’s “mini” Budget.

Under the recommendations, money market funds would have to hold up 50 to 60 per cent of their funds in assets that can be liquidated within seven days.

The current requirement is 30 per cent, though the industry average is about 45 to 50 per cent. Sterling denominated money market funds have £250bn of assets, though much of this is held in the EU.

The BoE stressed the importance of international co-ordination around measures to reduce risk in the funds industry.

The Financial Conduct Authority, which supervises money market funds, and the Treasury will consult on the UK’s requirements later this year. The US has already announced a weekly liquidity requirement of 50 per cent.

The BoE’s financial stability experts also announced an overhaul of next year’s banking stress test to better capture the risks from a prolonged era of high interest rates after more than a decade of loose monetary policy.  

The bank stress tests are an annual exercise introduced in the aftermath of the financial crisis to ensure lenders were well prepared for potential crises.

The central bank announced that it will run an in-house exercise in 2024 testing against a range of shocks. Results will be published for the system as a whole.

The BoE usually asks eight named banks to run their own stress tests against a single scenario and publishes each bank’s results individually. It plans to return to that structure from 2025.

The statement on Tuesday separately noted that hedge funds continued to have “material leveraged positions in US Treasuries” and said it would “continue to monitor risks to core market function and broader financial stability posed by leveraged trades in government bond markets”.

In their assessment of the UK’s outlook, the BoE said that households were “under pressure” from higher living costs and noted a rise in the percentage of households with a high debt burden, though the level is still below its 2007 peak.

Households have responded to higher rates by stretching out mortgages for longer, and 12 per cent of mortgages are now for 35 years or more, versus 4 per cent in the first quarter of 2021, the assessment said.

The BoE said that while this trend would reduce payments now, this could “increase debt burdens over the longer term”.

>>> US Early premarket gappers

Early premarket gappers
  • Gapping up:
    • NSTG +20%, AKRO +14.1%, U +7.7%, LXRX +7%, H +5.3%, PSTX +4.4%, PEP +2.8%, STLA +2.7%, BKD +1.6%, AOS +1.5%, NDAQ +1%, INMD +0.8%, HON +0.8%, FLR +0.6%
  • Gapping down:
    • VTYX -17.5%, PD -6.2%, XENE -0.7%

>>> Europe : Brokers Upgrades & Downgrades - 10th of October 2023 V2(+)

>>> Up
* Bayer Raised to Hold at HSBC; PT 43 euros
* BioPharma Credit Raised to Buy at Stifel (+)
* Chr. Hansen Raised to Buy at DNB Markets; PT 536 kroner
* Eiffage Raised to Buy at Jefferies; PT 115 euros
* Novozymes Raised to Buy at DNB Markets; PT 350 kroner
* Pagegroup's MSCI ESG Rating Raised to A from BBB
* Sacyr Raised to Buy at Alantra Equities; PT 3.60 euros (+)
* SSAB Raised to Overweight at Barclays; PT 85 kronor
* Swedbank Raised to Buy at Deutsche Bank; PT 260 kronor
* Tele2 Raised to Buy at Redburn; PT 96 kronor (+)
* Viaplay Raised to Hold at DNB Markets; PT 30 kronor
* Wolters Kluwer PT Raised to 142 euros at Morgan Stanley

>>> Down
* Croda Cut to Hold at HSBC; PT 5,000 pence
* EuroAPI Cut to Neutral at Oddo BHF; PT 11.80 euros (+)
* Euronav Cut to Hold at Stifel; PT 17.49 euros
* Euronav Cut to Neutral at Citi; PT 17.56 euros
* Fluidra Cut to Underperform at BNPP Exane; PT 15 euros
* Outokumpu Cut to Equal-Weight at Barclays; PT 4.30 euros
* Starwood Property Cut to Market Perform at KBW; PT $20
* Telenor Cut to Sell at DNB Markets; PT 110 kroner
* Tesla PT Cut to $250 from $265 at Jefferies
* Vitesco Cut to Hold at HSBC; PT 93 euros
* Vitesco Cut to Hold at M.M. Warburg; PT 91 euros (+)
* YIT Cut to Sell at Inderes; PT 1.60 euros

>>> Initiation
* ARM Holdings PLC ADRs Rated New Buy at Daiwa; PT $63
* ARM Holdings PLC ADRs Rated New Outperform at Oddo BHF; PT $70
* ARM Holdings PLC ADRs Rated New Buy at BofA; PT $65(Earlier)
* AutoZone Rated New Outperform at Cowen; PT $2,975
* Frontier Developments Reinstated Under Review at Liberum
* H&M Rated New Accumulate at Inderes; PT 165 kronor (+)
* Maersk Reinstated Equal-Weight at Morgan Stanley
* Sandoz Group Rated New Buy at Redburn; PT 47 Swiss francs (+)
* Schlumberger Rated New Buy at SocGen on Decades of Growth
* Sensirion Rated New Market Perform at ZKB (+)
* Severn Trent Reinstated Outperform at BNPP Exane; PT 2,725 pence
* SKF Reinstated Underweight at Barclays; PT 162 kronor
* Trelleborg Rated New Overweight at Barclays; PT 324 kronor
* Vinfast Auto Ltd Rated New Buy at Chardan Capital Markets

>>> Call
*Citi’s Montagu Says US Futures Positioning Is Moderately Bearish (+)
* Eiffage Raised to Buy at Jefferies, Cautious on Fraport, Skanska
* EuroAPI Estimates Slashed at Morgan Stanley Following Warning
* Fluidra Cut as BNPP Exane Questions if Earnings Yet at Trough (+)
* Maersk Equal-Weight, Net Cash Protects Downside: Morgan Stanley